Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
Clinical trial NCT05467826 · UNKNOWN
Trial details
- NCT number
- NCT05467826
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.